Loading stock data…
$11.98-0.11 (-0.91%)
908 Devices Inc.
908 Devices Inc. in the Healthcare sector is trading at $11.98 with a market capitalization of $405M. Wall Street consensus targets $13.38 (4 analysts), implying a +11.6% move over the next 12 months. The stock is currently near its 52-week high of $13.35, remaining 50.1% above its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the safe zone. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $16.07M↑ | $13.38M↓ | $17.38M↑ | $14.01M↑ | $13.04M |
| Gross Profit | $8.34M↑ | $6.88M↓ | $9.15M↑ | $7.36M↑ | $6.37M |
| Operating Income | -$6.37M↑ | -$6.50M↓ | -$3.17M↑ | -$5.62M↑ | -$8.37M |
| Net Income | -$11.89M↑ | -$11.96M↓ | $4.17M↑ | -$14.98M↓ | -$13.31M |
908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company's products include MX908, a handheld, battery-powered, and Mass Spec device ...